HEOR Policy Experts Present Drug Pricing Reform Options, Discuss FDA’s Accelerated Approval Mechanism and Pricing Negotiation
Health economics and outcomes research (HEOR) experts at the USC-Brookings Schaeffer Initiative for Health Policy and the Washington University School [...]
New JMCP Article on International Reference Pricing Assesses Global Models
Drs. Leah Rand and Aaron Kesselheim recently published an article in the Journal of Managed Care and Specialty Pharmacy (JMCP) [...]
PhRMA President Discusses Patient Centricity in Value Assessments
President of Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation Eileen Cannon shared her thoughts on adding a patient-centered component [...]
On-Demand CE Course on Effective Novel Gene Therapies in Hemophilia; Implementing Value-Based Coverage Policies
Novel gene therapies are of particular interest in treating hemophilia. Despite promises of efficacy and even curing the disease for [...]
Read the New Certara Blog Post on Succeeding in Value Communication
Certara’s Senior Digital Marketing Executive Tom Hemy discusses the steps that make up successful value communication. Rather than using spreadsheets [...]
New Article Reveals Modeling Method to Evaluate Costs of Value-Based Care
A recent article, published in the American Journal of Managed Care, highlights a new method designed to evaluate the costs [...]
ICER to Evaluate Value and Efficacy of Five COVID-19 Treatments
The Institute for Clinical and Economic Review (ICER) announced it will carry out assessments for five drugs used to treat [...]
Commonwealth Fund Report Highlights Poor Outcomes and Equity in the United States Despite High Healthcare Costs
The Commonwealth Fund has published a report detailing healthcare costs, outcomes, equity, and access to care worldwide. The United States [...]
Vanderbilt Scientist and Aetion RWE Strategist Highlight Seven Solutions to Bolster FDA’s Accelerated Approval Process and Achieve Value-Based Pricing
Aetion’s Dr. Nirosha Mahendraratnam Lederer and Vanderbilt’s Dr. Stacie B. Dusetzina discuss how value-based pricing may be achieved using the [...]
Novartis and University of California-Berkeley Researchers Estimate $93 Billion Wasted Yearly Across Healthcare Stakeholders, Propose Value-Based Pricing System
Researchers at the University of California-Berkeley and Novartis note that $93 billion is wasted yearly in addressing healthcare utilization management, [...]
COVID-19 Shakes Up Business, Prompts Employers to Consider Value-Based Care
The COVID-19 pandemic has accelerated the rise in healthcare costs. Now, employers are considering value-based care instead of traditional healthcare [...]
Costly Oncology Drugs Face ICER Scrutiny and Calls for Value-Based Pricing
Novel drugs used in cancer treatment, including chimeric antigen receptor (CAR)-T cell therapies, are increasing in popularity. However, their cost [...]
Whitepaper Finds Digital Value-Based Care Reduces Readmission Rates of Patients With Congestive Heart Failure
Veta Health sponsored research into how digital disease management tools could reduce hospital readmissions for patients with Congestive Heart Failure [...]
Effective Value-Based Healthcare Requires Rejecting Inferior Approaches and Promoting Health Equity
Although many approaches to value-based healthcare have been proposed or implemented in recent years, not all of them adequately address [...]
HEOR Article Notes Intricacies of Well-Being Valuation Approach to Quantitatively Determine Healthcare Value
A recent article, published in Health Economics, considers methods used to assess healthcare value and therapeutic cost-effectiveness. The researchers used [...]
JAMA Article Finds Medicare Overspent on Generics by $2.6 Billion, Costco Delivered Better Value
A recent article published in JAMA Internal Medicine compares Medicare drug spending on generics to Costco. The researchers found that [...]
CEVR Researcher and Author Dan Ollendorf Discusses QALYs, Reducing Prescription Drug Prices Using Value, and HTAs
Dr. Dan Ollendorf of the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts University Medical [...]
JMCP Article Highlights Impact of Patient Experience on Value Framework
A recent article, published in the Journal of Managed Care and Specialty Pharmacy (JMCP), discusses how to incorporate the patient [...]
Transitioning to Value-Based Care Requires Understanding Perceptions and Opening Up the Conversation to Diverse Stakeholders
Healthcare stakeholders hold different perceptions of value-based care, with some stakeholders associating “value” with sub-optimal care. A recent ISPOR article, [...]
Friday ISPOR Webinar on Value-Based Pricing
ISPOR will host a webinar on the intersection between price and value. Speakers include Omnicom’s Head of Global Health Accounts [...]
ISPOR Article Discusses Assigning Value to Novel Therapies
A new article, published in ISPOR’s Value in Health journal, discusses widespread research and development trends. Although exciting new scientific [...]
New ISPOR Article Compares Net Drug Prices and ICER’s Value-Based Prices
A new article, published in ISPOR’s Value in Health journal, assesses drug prices by comparing net prices to the Institute [...]
Biogen Partners with Cigna and CVS Health to Promote Access to Contentious Alzheimer’s Drug
Biogen has announced that it will partner with Cigna and CVS Health to improve patient access to aducanumab, which received [...]
CEVR Researchers Publish Article on Strengths of Value-Based Healthcare and HTAs
Leading researchers at Tufts University School of Medicine’s Center for the Evaluation of Value and Risk in Health (CEVR) have [...]
Survey Shows Americans Strongly Support Medicare Negotiation Amid Pharma’s Claims of Negative Impact to Innovation
A new survey shows that most Americans, both Democrats and Republicans, support negotiation by the federal government in prices of [...]